Skip to main content
Why SubmitSubmit

cGMP and ICHQ7a

GalactoseGalactose

Loading preview...

Use cases

Law notesLaw notes

About

The cGMP and ICHQ7a mind map provides a comprehensive overview of Current Good Manufacturing Practice regulations and ICH Q7A guidelines for pharmaceutical manufacturing. Covering 108 nodes across key areas such as Manufacturing Objectives, 21 CFR Parts 210 and 211, and ICH Q7A, this template serves as a cheat sheet for professionals navigating drug development phases from Phase I through Post Launch. It includes specific regulatory references like 'part 210 - CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING< PROCESSING< PACKING< OR HOLDING OF DRUGS GENERAL' and 'part 211 - CGMP FOR FINISHED PHARMACEUTICALS', detailing requirements for Quality Control Unit, Personnel Qualifications, and Facilities. The map also outlines the distinction between API and drug product under ICH Q7A, making it an essential study aid for regulatory compliance.

Terms and Conditions

When to use this template

Regulatory affairs managers and quality assurance teams

Preparing for an FDA pre-approval inspection during Phase III of drug development.

Training coordinators and quality control unit personnel

Training new staff on cGMP requirements for finished pharmaceuticals under 21 CFR Part 211.

API manufacturing managers and compliance officers

Reviewing ICH Q7A guidelines for active pharmaceutical ingredient manufacturing to ensure compliance.

How to use this template

Step 1

Open and Explore Core Regulatory Branches

Open the template in Xmind to navigate through the primary branches covering Manufacturing Objectives, 21 CFR, and ICH Q7A guidelines.

Step 2

Expand Nodes for Detailed Compliance Requirements

Click on specific nodes like Part 211 or API distinctions to reveal detailed sub-nodes regarding Quality Control, Personnel, and Facilities.

Step 3

Customize and Export Your Regulatory Map

Add personal notes or highlight key regulations before exporting the map as a PDF or image for team collaboration and sharing.

Frequently asked questions

The template covers Manufacturing Objectives, Current Good Manufacturing Practice, 21 CFR Parts 210 and 211, ICH Q7A, and Manufacturing in Drug Development phases. It includes 108 nodes with detailed regulatory requirements.

Open the .xmind file in Xmind, then explore branches like '21 CFR Part 211' to review specific subparts (e.g., Organization and Personnel, Buildings and Facilities). Customize nodes by adding your own facility's procedures.

Yes, the Xmind template is fully editable. You can add, remove, or modify nodes to suit your needs. Export as PDF or image for printing.

Part 210 contains minimum cGMP for all drugs, while Part 211 focuses specifically on CGMP FOR FINISHED PHARMACEUTICALS, with detailed subparts like Equipment and Laboratory Controls.

Use it during Phase I to understand regulatory exemptions, Phase II to plan manufacturing and stability programs, and during Marketing Application Review to ensure compliance with approved CMCs.

Got an inspiring template?

Share your mind map templates with creators around the world and start earning from your work.

Free template